Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kiora Pharmaceuticals, Inc.
Market Cap
$11.17M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.26M
Operating Margin
-21.94%
TTM Avg
-34.04%
3Y Avg
-49.86%
5Y Avg
-59.16%
Market Cap
$10.88M
Operating Margin
-10711.18%
TTM Avg
-6476.04%
3Y Avg
-3238.02%
5Y Avg
-2158.68%
Market Cap
$10.76M
Operating Margin
-293.46%
TTM Avg
-272.89%
3Y Avg
-2404.23%
5Y Avg
-2129.99%
Market Cap
$10.75M
Operating Margin
N/A
TTM Avg
-2960.13%
3Y Avg
-1713.73%
5Y Avg
-1142.49%
Market Cap
$11.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.82M
Operating Margin
-5652.38%
TTM Avg
-2826.19%
3Y Avg
-9617.03%
5Y Avg
-6411.35%
Market Cap
$10.52M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. (KPRX) | $11.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.26M | -21.94% | -34.04% | -49.86% | -59.16% |
| BioVie Inc. (BIVI)vs › | $11.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.88M | -10711.18% | -6476.04% | -3238.02% | -2158.68% |
| Cerenome, Inc. (CNSY)vs › | $10.76M | -293.46% | -272.89% | -2404.23% | -2129.99% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.75M | N/A | -2960.13% | -1713.73% | -1142.49% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.82M | -5652.38% | -2826.19% | -9617.03% | -6411.35% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lantern Pharma Inc. (LTRN)vs › | $11.87M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 82.64% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -9698.80% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 30.85% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | -1010.45% |
| 2018-06-30 | -1156.27% |
| 2018-03-31 | -217.06% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | -5542.60% |
| 2017-06-30 | -2243.44% |
| 2017-03-31 | -1582.17% |
| 2016-12-31 | -2307.82% |
| 2016-09-30 | -1231.17% |
| 2016-06-30 | -1630.90% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
